Browse diseases

…correlates with inflammatory activity and treatment response in multiple sclerosis (MS). We sought to determine the utility of a single sNfL in pr…

…ground/Objectives Due to regulatory restrictions, children with multiple sclerosis (MS) often do not receive highly effective monoclonal antibodie…

…kground/Objective Cognitive fatigability (CF) affects many with Multiple Sclerosis (MS), yet measurement remains challenging due to poor correlati…

…lerosis(MS) and psoriasis. We propose that the co-occurrence of psoriasis and MS (PsoMS) represents a distinct clinical variant of MS,cha…

…ce of pregnancy on the disease course in women with progressive multiple sclerosis (MS) phenotypes has not been defined. The objective of this stu…

…Background Despite advances in multiple sclerosis (MS) management, the need for more accurate biomarkers remains …

… (NfL) may help predict confirmed disability worsening (CDW) in multiple sclerosis (MS). However, data on the prognostic value of their blood conc…

…er (GM) atrophy is associated with cognitive impairment (CI) in multiple sclerosis (MS). We aimed to investigate the predictive role of early regi…

…nd reduced persistence to disease-modifying therapies (DMTs) in multiple sclerosis (MS) have been identified. Limited information is available reg…

…ges and predictors of autonomic dysfunction (AD) in people with multiple sclerosis (pwMS) over a 6-year period from disease onset.Methods Among th…

…Background Multiple sclerosis (MS) progression independent of relapses is driven by brain inn…

…ianakas A, Herzog S, Landmann A, et al. Successful treatment of discoid lupus erythematosus with fumaric acid esters. J Am Acad Dermatol. 2014;71(1):e15–7.…